Top stories in health and medicine, September 30, 2014
From MedPage Today:
Data Confirm Anti-ALK Activity in Rare NSCLC. Objective responses occurred in 72% of patients with mutation-specific non-small cell lung cancer (NSCLC) treated with crizotinib (Xalkori).
Case Reports: PET Imaging in Dementia. In two cases of progressing dementia, PET imaging with amyloid and tau tracers helped to clarify the diagnosis by ruling out Alzheimer’s disease.
Screen for Pre-Diabetes, Experts Say. Four prominent diabetes experts have called on physicians to screen essentially everyone for pre- and early diabetes and to initiate treatment in those with these conditions.
A New Standard of Care in HER2 Breast Cancer. Women with metastatic HER2-positive breast cancer had a median overall survival (OS) approaching 5 years when treated with a combination of two anti-HER2 antibodies, final results of a randomized trial showed.
Your patients are rating you online: How to respond. Manage your online reputation: A social media guide. Find out how.
Source: Kevin, M.D. - Medical Weblog - Category: Journals (General) Authors: MedPage Today Tags: News Cancer Diabetes Endocrinology Neurology Source Type: blogs
More News: Alzheimer's | Blogging | Brain | Breast Cancer | Cancer | Cancer & Oncology | Dementia | Diabetes | Endocrinology | Family Physicians | Health | HER2 | Lung Cancer | Neurology | Non-Small Cell Lung Cancer | Women